Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

3.6%

3 terminated/withdrawn out of 83 trials

Success Rate

94.4%

+7.8% vs industry average

Late-Stage Pipeline

20%

17 trials in Phase 3/4

Results Transparency

4%

2 of 51 completed trials have results

Key Signals

10 recruiting2 with results

Enrollment reporting

Analytics

N/A
37(63.8%)
Phase 4
12(20.7%)
Phase 3
5(8.6%)
Phase 1/2
2(3.4%)
Phase 2
2(3.4%)
58Total
N/A(37)
Phase 4(12)
Phase 3(5)
Phase 1/2(2)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (83)

Showing 20 of 83 trials
NCT07894601Not ApplicableNot Yet Recruiting

Virtual Reality Intervention to Improve Comfort in Hospitalized Hematology Patients

Role: lead

NCT07827378Not Yet Recruiting

Early Discharge After Colorectal Surgery

Role: lead

NCT07828847Not ApplicableRecruiting

Involvement of Muscle Mitochondrial Dysfunction in Frailty in Older Adults. Role of Exercise

Role: lead

NCT06418932Not ApplicableCompleted

Compression Therapy of the Lower Limbs in Patients With Decompensated Heart Failure

Role: lead

NCT07821333Phase 2Active Not Recruiting

Circulating Tumor DNA Based Decision for Adjuvant Treatment in Colon Cancer Stage II-III

Role: lead

NCT06582342Recruiting

Is the 3D-PANC MSP Model Superior to CT for Assessing Response to Neoadjuvant Treatment in PCA Patients?

Role: lead

NCT07816562Phase 3Recruiting

Ovulation Trigger Strategies in Low Ovarian Reserve (TRIGGERBEST)

Role: lead

NCT06578065Not ApplicableRecruiting

Colorectal Anastomosis Outcomes Using the Novel Powered Circular Stapler Compared With Manual Circular Staplers.

Role: lead

NCT06578520Phase 4Active Not Recruiting

Effect of the Use of Dapagliflozin in Patients With Refractory Heart Failure

Role: lead

NCT06578533Phase 3Recruiting

Keeping RAASi Treatment With Optimal Potassium Control

Role: lead

NCT05016466Completed

GOLD 0 - DLCO 1: A Look Beyond the Obstruction. Is Spirometry Enough for COPD (Chronic Obstructive Pulmonary Disease) Screening?

Role: lead

NCT06851962Phase 4Completed

Impact of Pharmacogenetic-Guided Treatment on Type 2 Diabetes.

Role: lead

NCT07727096Not ApplicableNot Yet Recruiting

Exercise-Based Cardiac Rehabilitation for Patients With Heart Failure With Preserved Ejection Fraction (EMPOWER-HFpEF)

Role: lead

NCT07476859Phase 4Recruiting

Effect of Intravenous Iron on Quality of Life in Older Patients With Acute Coronary Syndrome

Role: lead

NCT06578078Phase 3Recruiting

A Clinical Trial to Define the Best Strategy for the Management of Heart Failure in Elderly Patients

Role: lead

NCT07291999Active Not Recruiting

Tissue Characterization in STEMI Using Cardiac MRI: a Multicenter Registry

Role: lead

NCT06992089Not ApplicableRecruiting

SHort Of Pace - Heart Failure (SHOP-HF)

Role: lead

NCT07191574Active Not Recruiting

Stress CMR With Vasodilators to Predict Long-Term Mortality

Role: lead

NCT04031872Phase 1/2Withdrawn

LY3200882 and Capecitabine in Advanced Resistant TGF-beta Activated Colorectal Cancer (EORTC1615)

Role: collaborator

NCT06002022Not ApplicableRecruiting

Evaluation of Improvements in Patient-reported Quality of Life

Role: lead